CClinicalTrials.gg
CompletedNCT05810337Updated Apr 12, 2023

Splenda: Effects on Blood Glucose Concentration, Appetite Scores and Subsequent Energy Intake

An interventional study of Splenda drink and Maltodextrin drink in Appetitive Behavior and Glucose Metabolism Disorders, sponsored by King's College London. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-12.

Sponsored by King's College London · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
51
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

This study investigates the effects of Splenda, an artificial sweetener powder containing sucralose, on post-prandial blood glucose levels, appetite scores and subsequent energy intake.

Read the detailed description

Participants are randomly assigned to receive either the placebo drink (4.5g maltodextrin dissolved in 250ml water) or the Splenda drink (4.5g Splenda dissolved in 250ml water) taken alongside a high calorie breakfast.

Blood glucose measurements will be obtained through finger-pricking and appetite will be measured using self-reported visual analogue scores rating hunger, desire to eat, fullness and alertness for up to 3 hours after breakfast. Energy intake will be measured using a 24 hour food diary.

02

Conditions studied

  • Appetitive Behavior
  • Glucose Metabolism Disorders

Keywords

  • Blood glucose
  • Appetite
  • Energy intake
03

In context

Metabolic Diseases

997 studies on the registry are indexed under Metabolic Diseases; 234 are open to participants now.

This study's enrollment of 51 is close to the median of 48 across 670 interventional studies indexed under Metabolic Diseases.

Browse Metabolic Diseases studies →

Lead sponsor

King's College London is the lead sponsor of 506 studies on the registry; 125 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy male and female adults (18-64 years)

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
51 participants (actual)

Study arms

  • Experimental
    Splenda drink

    Drink containing 4.5g Splenda dissolved on 250ml water.

    Dietary Supplement: Splenda drink · Dietary Supplement: High carbohydrate breakfast

  • Placebo comparator
    Maltodextrin drink

    Drink containing 4.5g maltodextrin dissolved on 250ml water.

    Dietary Supplement: Maltodextrin drink · Dietary Supplement: High carbohydrate breakfast

Interventions

  • Dietary supplementSplenda drink

    4.5g Splenda containing 1% sucralose, 95% maltodextrin, dissolved in 250ml water and consumed with a high carbohydrate breakfast.

  • Dietary supplementMaltodextrin drink

    4.5g maltodextrin dissolved in 250ml water and consumed with a high carbohydrate breakfast.

  • Dietary supplementHigh carbohydrate breakfast

    Meal consisting of 30g cereal with 100ml skimmed milk, 1.5 slices white toast with 12g margarine, providing 386kcal, 61.4g carbohydrate, 10.4g protein and 10.1g fat.

06

What researchers measure

Primary outcomes

  1. Change in blood glucose

    Capillary blood glucose from fingerprick and measured using glucose monitor

    Time frame: -5 to 180 minutes (measured from baseline up to 90min every 15min and from 90-180min every 30min)

  2. Change in appetite

    Feelings of hunger, desire to eat, fullness and alertness measured using Visual Analogue Scale (VAS)

    Time frame: -5 to 180 minutes (measured from baseline up to 90min every 15min and from 90-180min every 30min)

Secondary outcomes

  1. 24 hour energy intake

    Food intake over the 24 hours of the study day using a 24 hour food diary entered into dietary analysis software

    Time frame: 0 - 24 hours

07

Study locations

1 site
  • King's College London
    London, SE1 9NH, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05810337
Lead sponsor
King's College London
Responsible party
Dr Christopher Corpe (Nutrition Sciences Lecturer, Principal investigator, King's College London) — Principal investigator
First posted
Apr 12, 2023
Start date
Jan 18, 2023
Primary completion
Feb 1, 2023
Completion
Mar 13, 2023
Last update
Apr 12, 2023

Study contacts

Christopher Corpe, Dr.
principal investigator · King's College London

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion